Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes
about
Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.Disruption of gut homeostasis by opioids accelerates HIV disease progressionMicroRNAs in opioid pharmacology.Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages.Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levelsHeroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.Current understanding of HIV-associated neurocognitive disorders pathogenesis.OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV.A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.Opioids and HIV/HCV infection.Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.Analysis of the V1V2 region of the SIV envelope in the brains of morphine-dependent and control SIV/SHIV-infected macaquesOutcomes associated with a cognitive-behavioral chronic pain management program implemented in three public HIV primary care clinics.CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
P2860
Q33610280-27AE5B7F-38F4-478F-9B14-4225569E31A0Q33861574-F847A5A3-0A03-4BEC-B4BF-4B33DF8881B9Q34270396-F72AC8C5-8CE1-4E44-A9E3-B54B4A1812D2Q35000656-5099CFCB-2614-4E89-A255-F9849878218CQ35282021-9D3E316A-6BE1-4DAB-92B9-CCAFE22445DDQ35782918-F9D7892B-B89C-4B09-A80E-88E619001CDEQ35809571-785C6A4B-1AF0-4372-BE34-DBCBB60B220BQ35883960-14352C59-8E85-4CA7-838F-E965245ECC11Q36211831-D2D6C9E3-CFDB-4161-8C2A-C5B263FBD629Q36245718-F7BDCD56-5E05-4011-A263-90CCFAF62CDCQ36458384-6F110D33-C17A-4FCB-A5FA-D4CB96AA5F1FQ36932005-C1682E14-3D4E-4862-80B4-E51C6AEC4C37Q37012052-EB7AD63B-8090-4652-BF27-810AF6347EB2Q37570243-2EE09D30-52F1-48B4-A000-9260715E3060Q37607856-34973712-B607-4284-8463-C251E32B7E85Q37611847-723C4F93-99BA-42A1-A455-4253C1561B23Q40002439-EC10D205-C374-4C7B-80AA-18FB2DE53CEBQ43888319-F12F9893-F7E0-486F-BBC7-C8B01CB6DD01Q45073147-ED3CB3CC-6DAB-4702-9E89-FC4FA2E03EFB
P2860
Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Methylnaltrexone antagonizes o ...... n blood mononuclear phagocytes
@ast
Methylnaltrexone antagonizes o ...... n blood mononuclear phagocytes
@en
type
label
Methylnaltrexone antagonizes o ...... n blood mononuclear phagocytes
@ast
Methylnaltrexone antagonizes o ...... n blood mononuclear phagocytes
@en
prefLabel
Methylnaltrexone antagonizes o ...... n blood mononuclear phagocytes
@ast
Methylnaltrexone antagonizes o ...... n blood mononuclear phagocytes
@en
P2093
P2860
P356
P1476
Methylnaltrexone antagonizes o ...... n blood mononuclear phagocytes
@en
P2093
Chang-Jiang Guo
Chun-Su Yuan
Jonathan Moss
Steven D Douglas
Wen-Zhe Ho
P2860
P304
P356
10.1124/JPET.103.056697
P407
P577
2003-10-14T00:00:00Z